Boston Scientific: Why This MedTech Giant Isn’t Slowing Down

Sep 17, 2024 · Boston Scientific Raises the Bar With Upside Guidance The company expects net sales for the third quarter of 2024 to grow 13% to 15% year over year and adjusted EPS …

13%
OFF

Boston Scientific: Why This MedTech Giant Isn’t Slowing Down

2 weeks from now

Sep 17, 2024 · Boston Scientific Raises the Bar With Upside Guidance The company expects net sales for the third quarter of 2024 to grow 13% to 15% year over year and adjusted EPS …

nasdaq.com

177%
OFF

Boston Scientific Standing Apart As A Rare Med-Tech Growth Story

2 weeks from now

1 day ago · Boston Scientific’s Farapulse is the early leader in the field, and it has driven some eye-popping numbers in recent quarters, with electrophysiology (or EP) growth of 177% in …

seekingalpha.com

$141.62
OFF

Boston Scientific's SWOT Analysis: Medtech Giant's Stock Poised …

2 weeks from now

Jan 8, 2025 · Boston Scientific Corporation (NYSE: NYSE:BSX), a leading player in the medical technology industry with a market capitalization of $141.62 billion, has been making significant …

investing.com

8%
OFF

Boston Scientific Q4 Misses Wall Street, A Laggard In Early Medtech ...

2 weeks from now

Jan 13, 2021 · Dive Brief: Boston Scientific's preliminary fourth-quarter sales of about $2.71 billion, a 6.8% decline on a reported basis, missed Wall Street expectations of $2.86 billion, …

medtechdive.com

$16.19
OFF

Boston Scientific Is Investing $16.19B On Medtech. What …

2 weeks from now

Boston Scientific has significantly invested in various Medtech initiatives, demonstrating its commitment to advancing healthcare technologies across several categories. The largest …

scitodate.com

63%
OFF

Boston Scientific Bucks The Medtech Slow Down And Raises …

2 weeks from now

Boston Scientific has two divisions: Cardiovascular and Medical Surgery (MedSurg). In Q1 2024, 63% of revenues came from the Cardiovascular segment, with $1.872 billion.

msn.com